AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,134,000 | -44.5% | 405,178 | -50.2% | 0.00% | -100.0% |
| Q3 2020 | $2,044,000 | -84.5% | 814,284 | -16.1% | 0.00% | -75.0% |
| Q2 2020 | $13,173,000 | +88.9% | 970,031 | +5.4% | 0.00% | +100.0% |
| Q1 2020 | $6,974,000 | +19.9% | 920,031 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,815,000 | +61.3% | 920,031 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $3,606,000 | -19.0% | 920,031 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $4,452,000 | -49.7% | 920,031 | -14.9% | 0.00% | -66.7% |
| Q1 2019 | $8,854,000 | +153.2% | 1,081,061 | +70.9% | 0.00% | +200.0% |
| Q4 2018 | $3,497,000 | +77.2% | 632,459 | +205.3% | 0.00% | 0.0% |
| Q1 2018 | $1,974,000 | -70.9% | 207,173 | -54.6% | 0.00% | -50.0% |
| Q4 2017 | $6,789,000 | -30.5% | 456,573 | -8.0% | 0.00% | -50.0% |
| Q3 2017 | $9,764,000 | +579.5% | 496,406 | +396.4% | 0.00% | +300.0% |
| Q2 2017 | $1,437,000 | +72.3% | 100,000 | +233.3% | 0.00% | – |
| Q2 2014 | $834,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |